{"product_id":"precision-medicine-market-report-2023-2033","title":"Precision Medicine Market Report 2023-2033","description":"\u003cp\u003ePrecision Medicine Market Report 2023-2033\u003c\/p\u003e\n\n\u003cp\u003eThe Precision Medicine Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.\u003c\/p\u003e\n\n\u003cp\u003eExpanding Applications of Precision Medicine and Rising Demand for Targeted Therapy\u003c\/p\u003e\n\n\u003cp\u003eWith regard to genetic disorders, precision medicine is becoming more prevalent. In the domains of neurogenetics, cardiovascular genomics, and rare illness genetic testing, this method is being employed more frequently. Additionally, non-invasive prenatal testing, pharmacogenomics, and screening genetic risk for hereditary diseases are also becoming more prevalent applications of precision medicine. A number of pharmaceutical companies are also concentrating on the creation of precision medicine for neurological conditions like Alzheimer's and Parkinson's disease. Pharmacological, biopharmaceutical, and pharmaceutical firms are continuously working to integrate patient-selection diagnostic frameworks into the earlier phases of drug development in order to deliver targeted therapies to the appropriate candidate and support the expansion of the precision medicine market. One of the main causes of the expanding usage of genomes and proteomics technologies as well as precision medicine is the increased understanding of the advantages of personalised medicine. Individualised treatment plans for many chronic diseases and conditions must include precision medicine, which entails the investigation of specific indications for particular medications in a given patient.\u003c\/p\u003e\n\n\u003cp\u003eHigh Cost of Precision Medicine\u003c\/p\u003e\n\n\u003cp\u003eAlthough personalized treatments are well-established in the pharmaceutical business, their cost continues to prevent payers, patients, and doctors from accessing them. Despite offering guaranteed returns on investment, the high initial cost of these tests makes them inaccessible to a huge majority of end users, particularly those in poor nations. As a result, end users like pharmaceutical firms, reference labs, medical facilities, and CROs who view the cost of such diagnostic procedures as a burden choose to use third-party precision diagnostic services. Inevitably, current medical privacy and investigation guidelines are inadequate to allow for the collection of enormous amounts of data on large patient populations, and private healthcare systems lack the infrastructure to do so, which drives up the price of precision medicine even more.\u003c\/p\u003e\n\n\u003cp\u003eWhat Questions Should You Ask before buying a Market Research Report?\u003c\/p\u003e\n\n\u003cp\u003eHow is the precision medicine market evolving?\u003c\/p\u003e\n\n\u003cp\u003eWhat is driving and restraining the precision medicine market?\u003c\/p\u003e\n\n\u003cp\u003eHow will each point of care diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?\u003c\/p\u003e\n\n\u003cp\u003eHow will the market shares for each precision medicine submarket develop from 2022 to 2033?\u003c\/p\u003e\n\n\u003cp\u003eWhat will be the main driver for the overall market from 2023 to 2033?\u003c\/p\u003e\n\n\u003cp\u003eWill leading precision medicine markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?\u003c\/p\u003e\n\n\u003cp\u003eHow will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?\u003c\/p\u003e\n\n\u003cp\u003eWho are the leading players and what are their prospects over the forecast period?\u003c\/p\u003e\n\n\u003cp\u003eWhat are the precision medicine projects for these leading companies?\u003c\/p\u003e\n\n\u003cp\u003eHow will the industry evolve during the period between 2023 and 2033? What are the implications of precision medicine projects taking place now and over the next 10 years?\u003c\/p\u003e\n\n\u003cp\u003eIs there a greater need for product commercialisation to further scale the precision medicine market?\u003c\/p\u003e\n\n\u003cp\u003eWhere is the precision medicine market heading and how can you ensure you are at the forefront of the market?\u003c\/p\u003e\n\n\u003cp\u003eWhat are the best investment options for new product and service lines?\u003c\/p\u003e\n\n\u003cp\u003eWhat are the key prospects for moving companies into a new growth path and C-suite?\u003c\/p\u003e\n\n\u003cp\u003eYou need to discover how this will impact the Precision Medicine market today, and over the next 10 years:\u003c\/p\u003e\n\n\u003cp\u003eOur 347-page report provides 149 tables, 220 charts, and graphs exclusively to you.\u003c\/p\u003e\n\n\u003cp\u003eThe report highlights key lucrative areas in the industry so you can target them – NOW.\u003c\/p\u003e\n\n\u003cp\u003eIt contains in-depth analysis of global, regional and national sales and growth.\u003c\/p\u003e\n\n\u003cp\u003eIt highlights for you the key successful trends, changes and revenue projections made by your competitors.\u003c\/p\u003e\n\n\u003cp\u003eThis report tells you TODAY how the Precision Medicine market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.\u003c\/p\u003e\n\n\u003cp\u003eForecasts to 2033 and other analyses reveal commercial prospects\u003c\/p\u003e\n\n\u003cp\u003eIn addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.\u003c\/p\u003e\n\n\u003cp\u003eYou will find original analyses, with business outlooks and developments.\u003c\/p\u003e\n\n\u003cp\u003eDiscover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Precision Medicine prices and recent developments.\u003c\/p\u003e\n\n\u003cp\u003eThis report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.\u003c\/p\u003e\n\n\u003cp\u003eSegments Covered in the Report\u003c\/p\u003e\n\n\u003cp\u003eProduct\u003c\/p\u003e\n\n\u003cp\u003eDiagnostic\u003c\/p\u003e\n\n\u003cp\u003e- Genetic Tests\u003c\/p\u003e\n\n\u003cp\u003e- Biomarker Based Tests\u003c\/p\u003e\n\n\u003cp\u003e- Other Diagnostic Tests\u003c\/p\u003e\n\n\u003cp\u003eTherapeutics\u003c\/p\u003e\n\n\u003cp\u003eApplication\u003c\/p\u003e\n\n\u003cp\u003eOncology\u003c\/p\u003e\n\n\u003cp\u003eCNS\u003c\/p\u003e\n\n\u003cp\u003eImmunology\u003c\/p\u003e\n\n\u003cp\u003eRespiratory\u003c\/p\u003e\n\n\u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eTechnology\u003c\/p\u003e\n\n\u003cp\u003eDrug Discovery\u003c\/p\u003e\n\n\u003cp\u003eBioinformatics\u003c\/p\u003e\n\n\u003cp\u003eBig Data Analytics\u003c\/p\u003e\n\n\u003cp\u003eGene Sequencing\u003c\/p\u003e\n\n\u003cp\u003eCompanion Diagnostics\u003c\/p\u003e\n\n\u003cp\u003eOther Technologies\u003c\/p\u003e\n\n\u003cp\u003eEnd-user\u003c\/p\u003e\n\n\u003cp\u003eHospitals\u003c\/p\u003e\n\n\u003cp\u003eDiagnostic Centres\u003c\/p\u003e\n\n\u003cp\u003eResearch \u0026amp; Academic Institutes\u003c\/p\u003e\n\n\u003cp\u003eOther End-users\u003c\/p\u003e\n\n\u003cp\u003eIn addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 25 leading national markets:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003c\/p\u003e\n\n\u003cp\u003eU.S.\u003c\/p\u003e\n\n\u003cp\u003eCanada\u003c\/p\u003e\n\n\u003cp\u003eEurope\u003c\/p\u003e\n\n\u003cp\u003eGermany\u003c\/p\u003e\n\n\u003cp\u003eUK\u003c\/p\u003e\n\n\u003cp\u003eFrance\u003c\/p\u003e\n\n\u003cp\u003eItaly\u003c\/p\u003e\n\n\u003cp\u003eSpain\u003c\/p\u003e\n\n\u003cp\u003eSwitzerland\u003c\/p\u003e\n\n\u003cp\u003eNetherlands\u003c\/p\u003e\n\n\u003cp\u003eRest of Europe\u003c\/p\u003e\n\n\u003cp\u003eAsia Pacific\u003c\/p\u003e\n\n\u003cp\u003eChina\u003c\/p\u003e\n\n\u003cp\u003eJapan\u003c\/p\u003e\n\n\u003cp\u003eIndia\u003c\/p\u003e\n\n\u003cp\u003eAustralia\u003c\/p\u003e\n\n\u003cp\u003eSouth Korea\u003c\/p\u003e\n\n\u003cp\u003eSingapore\u003c\/p\u003e\n\n\u003cp\u003eRest of Asia Pacific\u003c\/p\u003e\n\n\u003cp\u003eLatin America\u003c\/p\u003e\n\n\u003cp\u003eBrazil\u003c\/p\u003e\n\n\u003cp\u003eMexico\u003c\/p\u003e\n\n\u003cp\u003eArgentina\u003c\/p\u003e\n\n\u003cp\u003eRest of Latin America\u003c\/p\u003e\n\n\u003cp\u003eMEA\u003c\/p\u003e\n\n\u003cp\u003eGCC\u003c\/p\u003e\n\n\u003cp\u003eSouth Africa\u003c\/p\u003e\n\n\u003cp\u003eEgypt\u003c\/p\u003e\n\n\u003cp\u003eRest of MEA\u003c\/p\u003e\n\n\u003cp\u003eThe report also includes profiles and for some of the leading companies in the Precision Medicine Market, 2023 to 2033, with a focus on this segment of these companies’ operations.\u003c\/p\u003e\n\n\u003cp\u003eLeading companies and the potential for market growth\u003c\/p\u003e\n\n\u003cp\u003eAbbott\u003c\/p\u003e\n\n\u003cp\u003eAbnova Corporation\u003c\/p\u003e\n\n\u003cp\u003eAgilent Technologies Inc.\u003c\/p\u003e\n\n\u003cp\u003eAstraZeneca\u003c\/p\u003e\n\n\u003cp\u003eBayer AG\u003c\/p\u003e\n\n\u003cp\u003eBiogen\u003c\/p\u003e\n\n\u003cp\u003ebioMérieux SA\u003c\/p\u003e\n\n\u003cp\u003eBristol-Myers Squibb Company\u003c\/p\u003e\n\n\u003cp\u003eDanaher\u003c\/p\u003e\n\n\u003cp\u003eF. Hoffmann-La Roche Ltd\u003c\/p\u003e\n\n\u003cp\u003eGE HealthCare\u003c\/p\u003e\n\n\u003cp\u003eGSK plc\u003c\/p\u003e\n\n\u003cp\u003eIllumina, Inc.\u003c\/p\u003e\n\n\u003cp\u003eJohnson \u0026amp; Johnson Services, Inc.\u003c\/p\u003e\n\n\u003cp\u003eLaboratory Corporation of America Holdings\u003c\/p\u003e\n\n\u003cp\u003eLilly\u003c\/p\u003e\n\n\u003cp\u003eMyriad Genetics Inc.\u003c\/p\u003e\n\n\u003cp\u003eNanoString Technologies, Inc.\u003c\/p\u003e\n\n\u003cp\u003eNovartis AG\u003c\/p\u003e\n\n\u003cp\u003ePfizer Inc.\u003c\/p\u003e\n\n\u003cp\u003eQiagen\u003c\/p\u003e\n\n\u003cp\u003eQuest Diagnostics Incorporated\u003c\/p\u003e\n\n\u003cp\u003eTeva Pharmaceutical Industries Ltd.\u003c\/p\u003e\n\n\u003cp\u003eThermo Fisher Scientific Inc.\u003c\/p\u003e\n\n\u003cp\u003eOverall world revenue for Precision Medicine Market, 2023 to 2033 in terms of value the market will surpass US$78 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.\u003c\/p\u003e\n\n\u003cp\u003eHow will the Precision Medicine Market, 2023 to 2033 report help you?\u003c\/p\u003e\n\n\u003cp\u003eIn summary, our 340+ page report provides you with the following knowledge:\u003c\/p\u003e\n\n\u003cp\u003eRevenue forecasts to 2033 for Precision Medicine Market, 2023 to 2033 Market, with forecasts for product, mode, sample, platform, end user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.\u003c\/p\u003e\n\n\u003cp\u003eRevenue forecasts to 2033 for five regional and 25 key national markets – See forecasts for the Precision Medicine Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Switzerland, Netherlands, China, India, Japan, Australia, South Korea, Singapore, Argentina, GCC, South Africa, and Egypt among other prominent economies.\u003c\/p\u003e\n\n\u003cp\u003eProspects for established firms and those seeking to enter the market – including company profiles for 25 of the major companies involved in the Precision Medicine Market, 2023 to 2033.\u003c\/p\u003e\n\n\u003cp\u003eFind quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.\u003c\/p\u003e\n\n\u003cp\u003eInformation found nowhere else\u003c\/p\u003e\n\n\u003cp\u003eWith our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Precision Medicine Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.\u003c\/p\u003e\n\n\u003cp\u003ePlease Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher..\u003c\/p\u003e\n\n\u003cp\u003eThe publisher is using a password system to access single user and team licenses. Single user (non-printable) and team licenses expire after 12 month period. In the case of team license purchases, the publisher requires all email addresses for the licensed users prior to fulfilment.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"June, 2023 \/ 347 Pages \/ MCW16230894","offer_id":47647228657970,"sku":null,"price":5926.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/precision-medicine-market-report-2023-2033","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}